.png){kind=small}
.png){kind=small}
BackTable / Urology / Podcast / Episode #155
Managing Biochemical Recurrence After Prostatectomy
with Dr. James Eastham
In this episode of BackTable Urology, Dr. James Eastham, chief of urology at Memorial Sloan Kettering Cancer Center, discusses evolving approaches and treatments in prostate cancer.
This podcast is supported by:
Be part of the conversation. Put your sponsored messaging on this episode. Learn how.
BackTable, LLC (Producer). (2024, March 5). Ep. 155 – Managing Biochemical Recurrence After Prostatectomy [Audio podcast]. Retrieved from https://www.backtable.com
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Podcast Contributors
Dr. James Eastham
Dr. James Eastham is a urologic surgeon at Memorial Sloan-Kettering Cancer Center in New York City.
Dr. Aditya Bagrodia
Dr. Aditya Bagrodia is an associate professor of urology and genitourinary oncology team leader at UC San Diego Health in California and adjunct professor of urology at UT Southwestern.
Synopsis
First, he discusses topics such as patient preparation, pre-treatment discussions, and individualized treatment options based on the patient's risk levels. Dr. Eastham also summarizes crucial advancements in testing and imaging prostate cancers, including the use of genetic and biochemical markers, like PSA levels. Additionally, he emphasizes how advances in radiation therapy have improved treatment outcomes and patient experiences. Finally, Dr. Eastham emphasizes the need for consistent monitoring and communication with patients during and post-treatment.
Timestamps
00:00 - Introduction
06:24 - Treatment Strategies and Patient Preferences
11:30 - Exploring the Role of Imaging in Prostate Cancer Treatment
18:29 - Dealing with Persistently Detectable PSA and Pre-op Staging
27:48 - Understanding Prostate Cancer Recurrence
36:08 - The Role of PSA Doubling Time in Treatment Decisions
43:34 - The Future of Personalized Medicine and Genomic Classifiers in Prostate Cancer
52:42 - The Importance of Patient Education and Preparation
Resources
Decipher Prostate by Veracyte:
https://www.veracyte.com/decipher-prostate/
Transcript Preview
I tell them that this is just an event. It's obviously an event we didn't want to have you experience, but many patients in your situation are still potentially cured depending upon the individual situation.
Salvage radiation therapy cures many patients. Even if that's not curative, again, you're still going to live many years. I follow the same paradigm that you discuss. You let them know where they stand. They are likely going to need an additional treatment. The additional treatment is very effective and longevity is expected.
Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.
Up Next
Articles
Prostate Cancer Recurrence Diagnosis & Treatment: Focus on Shared Decision-Making
Biochemical Recurrence in Prostate Cancer: How to Assess Risk Before & After Prostatectomy
Topics
